BLACK FRIDAY SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim→
logo

CLSEL vs NATHBIOGEN: Stock Comparison

CHAMAN LAL SETIA EXP vs NATH BIO-GENES (I)Updated 20 Nov 26, 4:08 PM ISTNSE & company filings

CHAMAN LAL SETIA EXP is the larger company by market capitalisation. CHAMAN LAL SETIA EXP shows a higher ROE, faster revenue growth and lower leverage, while NATH BIO-GENES (I) shows a lower P/E, a higher dividend yield and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

CLSEL leads 8; NATHBIOGEN leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

CLSELNATHBIOGEN

Valuation lens

What price are you paying?

Market CapContext only
₹1,411 Cr
₹253 Cr
P/E RatioNATHBIOGEN has the lower reading
8.68x
8x ✓
P/B RatioNATHBIOGEN has the lower reading
1.52x
0.43x ✓
EPSCLSEL has the higher reading
₹11.32 ✓
₹0.22
Book ValueContext only
₹168.57
₹358.06
Dividend YieldNATHBIOGEN has the higher reading
1.06%
1.5% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
CLSEL is the larger company
₹1,411 Cr vs ₹253 Cr
P/E Ratio
NATHBIOGEN has a lower P/E
8x vs 8.68x
P/B Ratio
NATHBIOGEN has a lower P/B
0.43x vs 1.52x
EPS
CLSEL has higher earnings per share
₹11.32 vs ₹0.22
Dividend Yield
NATHBIOGEN has a higher dividend yield
1.5% vs 1.06%
Revenue Growth (TTM YoY)
CLSEL has faster revenue growth
16.5% vs -1%
EPS Growth (TTM YoY)
CLSEL has faster EPS growth
56.2% vs 0%
Qtr Sales Growth
CLSEL has stronger quarterly sales growth
-4.96% vs -87.59%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricCLSELNATHBIOGEN
SectorFast Moving Consumer GoodsFast Moving Consumer Goods
IndustryOther Agricultural ProductsOther Agricultural Products

Price

MetricCLSELNATHBIOGEN
Live Price₹283.25₹132.73
Day Change-0.7%-0.46%
Volume54,9272,217
52-Week High₹324.8₹204
52-Week Low₹203.75₹126.15
Distance from 52W High-12.79%-34.94%

Valuation

MetricCLSELNATHBIOGEN
Market Cap₹1,411 Cr₹253 Cr
P/E Ratio8.68x8x
P/B Ratio1.52x0.43x
EPS₹11.32₹0.22
Book Value₹168.57₹358.06
Dividend Yield1.06%1.5%

Growth

MetricCLSELNATHBIOGEN
Revenue Growth (TTM YoY)16.5%-1%
EPS Growth (TTM YoY)56.2%0%
Qtr Sales Growth-4.96%-87.59%
Qtr Profit Growth75.97%-98.7%

Profitability & Leverage

MetricCLSELNATHBIOGEN
ROE13.69%6.12%
ROCE13.13%-0.03%
Net Margin7.97%9.35%
Operating Margin11.31%14.46%
Debt to Equity0.1x0.2x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricCLSELNATHBIOGEN
Promoter Holding74.05%45.6%
FII Holding3.44%▲ 0.14 pp0.19%▼ 0.08 pp
DII Holding1.47%▼ 0.1 pp0.01%
Public Holding21.04%▼ 0.04 pp54.21%▲ 0.08 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: CHAMAN LAL SETIA EXP and NATH BIO-GENES (I).

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.